Live Biotherapeutic Products and Microbiome CDMO Market Size to...

a adăugat un sunet Alte

2026-04-09 12:22:43

Live Biotherapeutic Products and Microbiome CDMO Market Size to Reach USD 9.84 Billion by 2033, Growing at a CAGR of 18.2%

The global live biotherapeutic products (LBP) and microbiome contract development and manufacturing organization (CDMO) market is experiencing rapid growth, driven by increasing research in microbiome-based therapies and rising demand for outsourcing pharmaceutical development. Live biotherapeutics are emerging as a promising approach for treating a wide range of diseases, including...

0 Commentarii 0 Distribuiri 28 Views 0 previzualizare